Global Exclusive License Signed

After nearly 18 months of development and negotiation, we are pleased to announce that Protak Scientific have been selected to be the global exclusive partner for Public Health England (PHE) (which is an executive agency of the Department of Health in the United Kingdom), for the commercialisation and development of thermostable Adenylate Kinase for verification…

Compounded Sterile Drug Product Recalls Regarding Sterility and Quality Control

Compounded Sterile Drug Product Recalls Regarding Sterility and Quality Control – UPDATED April 2, 2015 FDA has alerted healthcare professionals and the public about multiple sterile compounding pharmacies having quality control and sterility issues. This alert does not include the New England Compounding Center information that was associated with fungal infections associated with their products.…

Global Exclusive License Signed

After nearly 18 months of development and negotiation, we are pleased to announce that Protak Scientific have been selected to be the global exclusive partner for Public Health England (PHE) (which is an executive agency of the Department of Health in the United Kingdom), for the commercialisation and development of thermostable Adenylate Kinase for verification…

The North Carolina Board of Pharmacy has ordered a recall for all lots of non-sterile and sterile products

The North Carolina Board of Pharmacy has ordered a recall for all lots of non-sterile and sterile products compounded, repackaged and distributed by Prescription Center Pharmacy located at 915 Hay Street, Fayetteville, NC, between September 10, 2014, and March 10, 2015. Contact: Consumer: 919-246-1050 FOR IMMEDIATE RELEASE — April 1, 2015 — Fayetteville, NC —…

The North Carolina Board of Pharmacy has ordered a recall for all lots of non-sterile and sterile products

The North Carolina Board of Pharmacy has ordered a recall for all lots of non-sterile and sterile products compounded, repackaged and distributed by Prescription Center Pharmacy located at 915 Hay Street, Fayetteville, NC, between September 10, 2014, and March 10, 2015. Contact: Consumer: 919-246-1050 FOR IMMEDIATE RELEASE — April 1, 2015 — Fayetteville, NC —…

Compounded Sterile Drug Product Recalls Regarding Sterility and Quality Control

Compounded Sterile Drug Product Recalls Regarding Sterility and Quality Control – UPDATED April 2, 2015 FDA has alerted healthcare professionals and the public about multiple sterile compounding pharmacies having quality control and sterility issues. This alert does not include the New England Compounding Center information that was associated with fungal infections associated with their products.…

FDA alert – Voluntary Recall – Potential Impact on Product Sterility

ISSUE: Sagent Pharmaceuticals, Inc. announced the voluntary nationwide recall of two lots of Atracurium Besylate Injection, USP, 50mg/5mL single-dose vials (NDC 25021-659-05) and four lots of Atracurium Besylate Injection, USP, 100mg/10mL multi-dose vials (NDC 25021-672-10) manufactured by Emcure Pharmaceuticals Ltd. and distributed by Sagent. Sagent has initiated this voluntary recall of Atracurium Besylate Injection, USP,…